2005
DOI: 10.18388/abp.2005_3423
|View full text |Cite
|
Sign up to set email alerts
|

New generation of peptide antibiotics.

Abstract: The increasing antibiotic resistance of pathogenic bacteria calls for the development of alternative antimicrobial strategies. Possible approaches include the development of novel, broad-spectrum antibiotics as well as specific targeting of individual bacterial virulence factors. It is impossible to decide currently which strategy will prove more successful in the future since they both promise different advantages, but also introduce diverse problems. Considering both approaches, our laboratory's research foc… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
12
0
1

Year Published

2006
2006
2016
2016

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 21 publications
(13 citation statements)
references
References 34 publications
0
12
0
1
Order By: Relevance
“…The function of a factor of virulence in pathogenic microorganisms lowering the vulnerability to the defence mechanisms of the hosts. Important for both Pro-and Eukaryotic pathogens, it draws one's attention in quest of specific targeting of individual microbial virulence factors as an alternative antimicrobial strategy (Dubin et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…The function of a factor of virulence in pathogenic microorganisms lowering the vulnerability to the defence mechanisms of the hosts. Important for both Pro-and Eukaryotic pathogens, it draws one's attention in quest of specific targeting of individual microbial virulence factors as an alternative antimicrobial strategy (Dubin et al, 2005).…”
Section: Discussionmentioning
confidence: 99%
“…As AMPs begin showing their potential as highly selective antitumor drugs, even against diseases resistant to chemotherapy (Dubin et al, 2005;Mader & Hoskin, 2006), this potential should be taken advantage of to solve the main problems in conventional anti-cancer chemotherapy: toxic side-effects, low response of slowgrowing tumors and dormant cells (Naumov et al, 2003) and the development of multi-drug resistance by tumor cells (Gottesman, 2002) even against anti-angiogenic drugs (Ferrara & Kerbel, 2005). Understanding the relationships between AMPs structure and antitumor activity would be helpful in the development of synthetic peptides with the highest antitumor activity and selectivity and low side-effects, e.g., haemolysis.…”
Section: Tnf-α Release In Supernatants Of U937 Cell Line Treated Withmentioning
confidence: 99%
“…Antimicrobial peptides (AMPs) constitute an evolutionarily conserved part of the innate immune defense mechanism found in a wide range of prokaryotic and eukaryotic organisms. They are active against bacteria, fungi, viruses and also take part in anti-tumor response making them promising candidates for therapeutic use (Lehrer & Ganz, 1999;Reddy et al, 2004;Dubin et al, 2005). Over 1000 AMPs have already been isolated and characterized at the level of their primary structure (Bulet et al, 2004).…”
Section: Introductionmentioning
confidence: 99%
“…Antimicrobial peptides are found in a variety of organisms and are considered the future of anti-infective therapy drugs. Antimicrobial peptides have active smallmolecule peptides with broad-spectrum antimicrobial activity and are a first line of defense for various living organisms, 6,7 with the advantages of high efficiency, broad spectrum, and little drug resistance.…”
Section: Introductionmentioning
confidence: 99%